YAP1 and hepatocellular carcinoma: For example, ROS production has been reported to lead to increased YAP mRNA and protein levels in hepatocellular carcinoma cells [48], while Ras activation- and mitochondrial dysfunction-stimulated ROS production can inactivate the Hippo pathway and induce metastatic behavior in benign tumors [49].